News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Emerging Biopharmaceutical Pharmaxon Announces Completion Of Seed Financing Round


10/2/2006 1:00:34 PM

Marseille (France), October3rd 2006 -- Pharmaxon, the Marseille-based emerging biopharmaceutical company specializing in the discovery and development of innovative drugs for nervous system disorders, today announced the completion of a seed financing round of over half a million euros. The funds will accelerate preclinical development of the company's ongoing programs. A number of respected investors (Inserm Transfert Initiative, Esperante, Primaveris and CAAP Création, a subsidiary of Crédit Agricole Alpes Provence) participated in various ways in the funding round, with the first three taking an equity stake in Pharmaxon.

Read at BioSpace.com

comments powered by Disqus
Pharmaxon
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES